Last 7 days
0.9%
Last 30 days
-3.9%
Last 90 days
-2.2%
Trailing 12 Months
9.3%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 104.1B | 18.4B | 2.26% | 8.00% | 44.16 | 5.64 | 7.84% | 18.25% |
ISRG | 84.2B | 6.2B | -4.47% | -13.27% | 63.66 | 13.53 | 8.97% | -22.43% |
BSX | 69.1B | 12.7B | 0.59% | 12.45% | 99.06 | 5.45 | 6.68% | -32.95% |
BDX | 67.4B | 19.0B | -5.16% | -6.78% | 41.86 | 3.55 | -0.43% | -8.78% |
EW | 49.8B | 5.4B | 2.41% | -25.12% | 32.74 | 9.26 | 2.86% | 1.25% |
MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 9.34% | 31.15% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.2B | 847.1M | -3.64% | 34.52% | -5.1K | 12.05 | 13.32% | -137.89% |
GMED | 5.2B | 1.0B | -11.64% | -20.31% | 30.19 | 5.09 | 6.76% | 24.45% |
IRTC | 3.5B | 410.9M | 4.51% | -3.13% | -29.82 | 8.43 | 27.29% | -14.60% |
TNDM | 2.7B | 801.2M | 1.13% | -58.87% | -28.25 | 3.34 | 14.00% | -707.69% |
SMALL-CAP | ||||||||
SILK | 1.7B | 138.6M | -15.68% | 29.18% | -30.43 | 12.07 | 36.62% | -10.44% |
ATEC | 1.6B | 350.9M | 10.38% | 49.06% | -10.84 | 4.7 | 44.26% | -5.42% |
AVNS | 1.3B | 820.0M | -8.35% | -12.22% | 25.89 | 1.59 | 10.13% | 701.59% |
CSII | 828.4M | 239.8M | 0.30% | 1.49% | -21.88 | 3.45 | -4.74% | -31.15% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 4.2% | 2,910 | 2,793 | 2,673 | 2,572 | 2,449 |
Gross Profit | 3.8% | 1,883 | 1,814 | 1,767 | 1,735 | 1,681 |
Operating Expenses | -3.6% | 1,492 | 1,548 | 1,530 | 1,474 | 1,415 |
S&GA Expenses | 6.6% | 1,000 | 938 | 902 | 840 | 807 |
R&D Expenses | -6.5% | 484 | 518 | 536 | 544 | 517 |
EBITDA | 30.2% | 565 | 434 | 385 | 366 | - |
EBITDA Margin | 24.9% | 0.19* | 0.16* | 0.14* | 0.14* | - |
Earnings Before Taxes | 48.0% | 391 | 264 | 230 | 252 | 257 |
EBT Margin | 42.1% | 0.13* | 0.09* | 0.05* | 0.07* | - |
Interest Expenses | 0% | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 |
Net Income | 39.8% | 341 | 244 | 230 | 258 | 217 |
Net Income Margin | 34.2% | 0.12* | 0.09* | 0.06* | 0.09* | - |
Free Cahsflow | 16.6% | 305 | 261 | 216 | 95.00 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 10.1% | 5,392 | 4,899 | 5,217 | 5,057 | 4,933 |
Current Assets | 8.0% | 3,669 | 3,399 | 3,809 | 3,747 | 3,684 |
Cash Equivalents | -8.0% | 642 | 698 | 735 | 716 | 1,053 |
Inventory | -1.4% | 307 | 311 | 340 | 342 | 357 |
Net PPE | 6.3% | 1,003 | 943 | 857 | 802 | - |
Goodwill | 4.0% | 26.00 | 25.00 | 26.00 | 27.00 | 27.00 |
Liabilities | 6.0% | 3,260 | 3,075 | 2,962 | 2,868 | 2,891 |
Current Liabilities | 104.3% | 1,839 | 901 | 807 | 711 | 721 |
Shareholder's Equity | 16.8% | 2,132 | 1,825 | 2,256 | 2,189 | 2,042 |
Retained Earnings | 23.7% | 480 | 388 | 287 | 236 | 139 |
Additional Paid-In Capital | 9.0% | 2,258 | 2,072 | 2,029 | 1,997 | 2,109 |
Shares Outstanding | 0.0% | 386 | 386 | 393 | 392 | 388 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 4.2% | 670 | 643 | 597 | 486 | 443 |
Share Based Compensation | 6.5% | 127 | 119 | 116 | 115 | 113 |
Cashflow From Investing | 36.7% | -521 | -823 | -1,023 | -515 | -216 |
Cashflow From Financing | 0.0% | -552 | -552 | 11.00 | 15.00 | 10.00 |
Buy Backs | Infinity% | 558 | 0.00 | 0.00 | - | - |
94.2%
32.7%
29.6%
Y-axis is the maximum loss one would have experienced if DexCom was unfortunately bought at previous high price.
39.5%
33.5%
47.3%
23.1%
FIve years rolling returns for DexCom.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | added | 54.5 | 348,701 | 762,701 | 0.02% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -18.85 | 13,905,700 | 112,600,000 | 0.12% |
2023-03-10 | BAILLIE GIFFORD & CO | reduced | -4.43 | 501,188,000 | 1,959,380,000 | 2.04% |
2023-03-08 | Capital Asset Advisory Services LLC | new | - | 206,210 | 206,210 | 0.02% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 1.45 | 4,034,000 | 13,495,000 | 0.07% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 225,121 | 225,121 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -15.21 | 18,713,000 | 427,682,000 | 0.60% |
2023-02-28 | Orin Green Financial, LLC | unchanged | - | 148,563 | 514,563 | 0.30% |
2023-02-27 | Parallax Volatility Advisers, L.P. | reduced | -99.77 | -2,063,210 | 6,794 | -% |
2023-02-24 | NATIXIS | added | 0.97 | 1,930,330 | 6,743,330 | 0.04% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 10, 2023 | blackrock inc. | 8.7% | 33,535,680 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 11.34% | 43,819,836 | SC 13G/A | |
Jan 27, 2023 | blackrock inc. | 8.7% | 33,882,680 | SC 13G/A | |
Jan 25, 2023 | blackrock inc. | 8.8% | 33,882,680 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 10.74% | 10,410,319 | SC 13G/A | |
Feb 08, 2022 | blackrock inc. | 8.4% | 8,128,454 | SC 13G/A | |
Dec 06, 2021 | baillie gifford & co | 4.85% | 4,700,380 | SC 13G/A | |
Feb 16, 2021 | price t rowe associates inc /md/ | 2.2% | 2,139,304 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 10.66% | 10,232,245 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 28.52 -75.10% | 36.46 -68.17% | 66.99 -41.52% | 109.59 -4.34% | 133.44 16.48% |
Current Inflation | 26.07 -77.24% | 32.84 -71.33% | 58.89 -48.59% | 94.82 -17.23% | 114.78 0.19% |
Very High Inflation | 23.05 -79.88% | 28.46 -75.16% | 49.35 -56.92% | 77.71 -32.17% | 93.30 -18.56% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 15, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-14 | Stern Sadie | sold | -43,961 | 111 | -393 | evp chief human resources offi |
2023-03-13 | Regan Barry J. | sold | -213,603 | 106 | -2,010 | evp operations |
2023-03-13 | Flynn Paul R | sold | -295,643 | 106 | -2,782 | evp global revenue |
2023-03-13 | Dolan Matthew Vincent | sold | -661,956 | 106 | -6,229 | svp corporate strategy-develop |
2023-03-10 | Stern Sadie | back to issuer | -681,205 | 111 | -6,115 | evp chief human resources offi |
2023-03-10 | Pacelli Steven Robert | back to issuer | -1,299,910 | 111 | -11,669 | evp managing director dexcom v |
2023-03-10 | Leach Jacob Steven | back to issuer | -1,794,530 | 111 | -16,109 | evp chief technology officer |
2023-03-10 | Abbey Donald | back to issuer | -1,299,910 | 111 | -11,669 | evp global business services i |
2023-03-10 | Regan Barry J. | back to issuer | -632,746 | 111 | -5,680 | evp operations |
2023-03-10 | Selvaraj Shelly Ramasamy | back to issuer | -720,974 | 111 | -6,472 | svp chief information officer |
Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | [1] | Sep. 30, 2022 | Sep. 30, 2021 | [1] | |||||||
Income Statement [Abstract] | ||||||||||||
Revenue | $ 769.6 | $ 650.2 | $ 2,094.6 | $ 1,750.3 | ||||||||
Cost of sales | 275.4 | 203.3 | 752.8 | 542.4 | ||||||||
Gross profit | 494.2 | 446.9 | 1,341.8 | 1,207.9 | ||||||||
Operating expenses: | ||||||||||||
Research and development | 110.3 | 128.8 | 367.9 | 367.3 | ||||||||
Amortization of intangible assets | 1.8 | 1.3 | 5.7 | 2.3 | ||||||||
Selling, general and administrative | 234.6 | 198.5 | 702.4 | 573.1 | ||||||||
Total operating expenses | 346.7 | 328.6 | 1,076.0 | 942.7 | ||||||||
Operating income | 147.5 | 118.3 | 265.8 | 265.2 | ||||||||
Interest expense | (4.6) | (4.6) | (13.9) | (14.1) | ||||||||
Income from equity investments | 0.0 | 0.0 | 0.2 | 0.0 | ||||||||
Interest and other income (expense), net | 3.3 | (1.7) | 5.5 | (0.7) | ||||||||
Income before income taxes | 146.2 | 112.0 | 257.6 | 250.4 | ||||||||
Income tax expense | 45.0 | 24.7 | 8.2 | 28.2 | ||||||||
Net income | $ 101.2 | $ 87.3 | [2] | $ 249.4 | $ 222.2 | [3] | ||||||
Basic net income per share (USD per share) | $ 0.26 | $ 0.23 | $ 0.64 | $ 0.57 | ||||||||
Shares used to compute basic net income per share (shares) | 389.8 | 387.4 | 390.4 | 386.5 | ||||||||
Diluted net income per share (USD per share) | $ 0.24 | $ 0.21 | $ 0.60 | $ 0.54 | ||||||||
Shares used to compute diluted net income per share (shares) | 425.8 | 430.3 | 428.0 | 427.9 | ||||||||
|
Consolidated Balance Sheets - USD ($) $ in Millions | Sep. 30, 2022 | Dec. 31, 2021 | [1] | ||
---|---|---|---|---|---|
Current assets: | |||||
Cash and cash equivalents | $ 698.1 | $ 1,052.6 | |||
Short-term marketable securities | 1,673.8 | 1,678.6 | |||
Accounts receivable, net | 564.1 | 514.3 | |||
Inventory | 311.0 | 357.3 | |||
Prepaid and other current assets | 151.5 | 81.6 | |||
Total current assets | 3,398.5 | 3,684.4 | |||
Property and equipment, net | 1,002.5 | 801.8 | |||
Operating lease right-of-use assets | 73.1 | 88.1 | |||
Goodwill | 24.7 | 26.5 | |||
Intangibles, net | 24.4 | 31.5 | |||
Deferred tax assets | 342.3 | 290.5 | |||
Other assets | 33.7 | 10.5 | |||
Total assets | 4,899.2 | 4,933.3 | |||
Current liabilities: | |||||
Accounts payable and accrued liabilities | 764.2 | 573.0 | |||
Accrued payroll and related expenses | 112.7 | 125.2 | |||
Short-term operating lease liabilities | 20.9 | 20.5 | |||
Deferred revenue | 2.7 | 2.1 | |||
Total current liabilities | 900.5 | 720.8 | |||
Long-term senior convertible notes | 1,968.8 | 1,981.8 | |||
Long-term operating lease liabilities | 82.1 | 98.6 | |||
Other long-term liabilities | 123.3 | 90.0 | |||
Total liabilities | 3,074.7 | 2,891.2 | |||
Commitments and contingencies | |||||
Stockholders’ equity: | |||||
Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at September 30, 2022 and December 31, 2021 | 0.0 | 0.0 | |||
Common stock, $0.001 par value, 800.0 million shares authorized; 393.1 million and 386.2 million shares issued and outstanding, respectively, at September 30, 2022; and 391.4 million and 388.0 million shares issued and outstanding, respectively, at December 31, 2021 | 0.4 | 0.4 | |||
Additional paid-in capital | 2,072.1 | 2,108.7 | |||
Accumulated other comprehensive income (loss) | (41.1) | 0.5 | |||
Retained earnings | 388.1 | 138.7 | |||
Treasury stock, at cost; 6.9 million shares at September 30, 2022 and 3.4 million shares at December 31, 2021 | (595.0) | (206.2) | |||
Total stockholders’ equity | 1,824.5 | 2,042.1 | |||
Total liabilities and stockholders’ equity | $ 4,899.2 | $ 4,933.3 | |||
|